The biosimilars market in Spain
Jaime Espín. Study Coordinator. EASP Professor
On Tuesday, February 27, 2024, an informative breakfast was held in which the report 'Study on the market for biosimilar medicines in the National Health System in Spain' was presented and the feasibility of having a possible observatory was discussed. on biosimilars in our country.
VIDEOS AND PRESENTATIONS
Diálogo: Towards a national observatory for biosimilars?
Moderated by Candela Calle. Member of the Spanish Society of Health Directors, SEDISA. General Director of the San Francisco de Asís Foundation
- Cesar Hernandez. General Director of the Common Portfolio of SNS and Pharmacy Services
- José María Casado. Director of the Public Expenditure Evaluation Division of the Independent Authority for Fiscal Responsibility, AIReF
- Felix Wolf. President of the Advisory Committee for Pharmaceutical Benefits and emeritus professor of the Carlos III University of Madrid
- Isabel del Río. BioSim Deputy Director